The t(8;21) translocation is not consistently associated with high Bcl- 2 expression in de Novo acute myeloid leukemias of adults

Clinical Cancer Research

Volumn 4, Issue 12, 1998, Pages 3051-3062

  Banker, Deborah E ^a,c   Radich, Jerald ^a   Becker, Abram ^a   Kerkof, Keith ^a   Norwood, Thomas ^a   Willman, Cheryl ^b   Appelbaum, Frederick R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC LINKAGE; HUMAN; LEUKEMOGENESIS; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTION REGULATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; BONE MARROW; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOASSAY; LEUKEMIA, MYELOID; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MUTATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRODUCIBILITY OF RESULTS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032407025     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nucifora, G., and Rowley, J. D. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21). Leuk. Lymphoma, 14: 353-362,1994.
2. Rhoades, K. L., Hetherington, C. J., Rowley, J. D., Hiebert, S. W., Nucifora, G., Tenen, D. G., and Zhang, D. E. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA, 93: 11895-11900, 1996.
3. Klampfer, L., Zhang, J., Zelenetz, A. O., Uchida, H., and Nimer, S. D. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA, 93: 14059-14064, 1996.
4. Ibrado, A. M., Huang, Y., Fang, G., Liu, L., and Bhalla, K. Over-expression of Bcl-2 or BcI-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res., 56: 4743-4748, 1996.
5. Salomoni, P., Perrotti, D., Martinez, R., Franceschi, C., and Calabretta, B. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of Bcl-2 promoter activity. Proc. Natl. Acad. Sci. USA, 94: 3296-3301, 1997.
6. Miyashita, T., Harigai, M., Hanada, M., and Reed, J. C. Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res., 54:3131-3135, 1994.
7. Hewitt, S. M., Hamada, S., McDonnell, T. J., Rauscher, F. J., III, and Saunders, G. F. Regulation of the proto-oncogenes Bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res., 55: 5386-5389, 1995.
8. Martinez-Climent, J. A., Lane, N. J., Rubin, C. M., Morgan, E., Johnstone, H. S., Mick, R., Murphy, S. B., Vardiman, J. W., Larson, R. A., Le Beau, M. M., and Rowley, J. D. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia (Baltimore), 9: 95-101, 1995.
9. Buchner, T., and Heinecke, A. The role of prognostic factors in acute myeloid leukemia. Leukemia (Baltimore), 10 (Suppl. 1): S28-S29, 1996.
10. Maung, Z. T., MacLean, F. R., Reid, M. M., Pearson, A. D., Proctor, S. J., Hamilton, P. J., and Hall, A. G. The relationship between Bcl-2 expression and response to chemotherapy in acute leukaemia. Br. J. Haematol., 88: 105-109, 1994.
11. Campos, L., Rouault, J. P., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J. P., and Guyotat, D. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 81: 3091-3096, 1993.
12. Lauria, F., Raspadori, D., Rondelli, D., Ventura, M. A., Fiacchini, M., Visani, G., Forconi, F., and Tura, S. High Bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate. Leukemia (Baltimore), 11: 2075-2078, 1997.
13. Pearson, L., Leith, C. P., Duncan, M. H., Chen, I. M., McConnell, T., Trinkaus, K., Foucar, K., and Willman, C. L. Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatrie acute myeloid leukemia. Leukemia (Baltimore), 10: 1274-1282, 1996.
14. Koeffler, H. P., Billing, R., Lusis, A. J., Sparkes, R., and Golde, D. W. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood, 56: 265-273, 1980.
15. Lozzio, C. B., and Lozzio, B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood, 45: 321-334, 1975.
16. Asou, H., Tashiro, S., Hamamoto, K., Otsuji, A., Kita, K., and Kamada, N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood, 77: 2031-2036, 1991.
17. Banker, D. E., Groudine, M., Norwood, T., and Appelbaum, F. R. Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia. Blood, 89: 243-255, 1997.
18. Banker, D. E., Groudine, M., Willman, C. L., Norwood, T., and Appelbaum, F. R. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposure to therapeutic agents. Leuk. Res., 22: 221-239, 1998.
19. Overton, W. R. Modified histogram subtraction technique for analysis of flow cytometry data [published erratum appears in Cytometry 10: 492-494, 1989]. Cytometry, 9: 619-626, 1988.